Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts

James E Littlejohn, Xiaobo Cao, Steven D. Miller, Mustafa K. Ozvaran, Daniel Jupiter, Lidong Zhang, Charles Rodarte, W. Roy Smythe

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts'. Together they form a unique fingerprint.

Medicine & Life Sciences